BACKGROUND: Cohorts describing cause specific mortality in HIV-infected patients initiating antiretroviral therapy (ART) operate on an outpatient basis. Hospitalized patients represent the spectrum and burden of severe morbidity and mortality in patients on ART. OBJECTIVE: To determine the causes and outcomes of hospitalization among adults receiving ART. METHODS: A prospective cohort study. We enrolled 201 participants (50% female) with median (IQR) age and CD4 count of 34 (28-40) years and 91(29-211) cells/uL respectively. RESULTS: The most frequent causes of hospitalization were tuberculosis (TB) (37, 18%), cryptococcal meningitis (22, 11%), zidovudine (AZT) - associated anemia (19, 10%), sepsis (10, 5%) and Kaposi's sarcoma (10, 5%). Forty two patients (21%) died: 10 (24%) had TB, 8 (19%) had cryptococcal meningitis and 5 (12%) had sepsis, 9 (21%) had undiagnosed neurological syndromes while 10 (24%) had other illnesses. Predictors of death included low Karnofsky performance score of < 40 (OR, 21.1; CI 1.43- 31.6) and age >34 years (OR, 7.65; CI 1.09- 53.8). CONCLUSIONS: Opportunistic infections, malignancy and AZT-associated anemia contributed to most hospitalizations and mortality. It is important to intensify prevention, screening, and treatment for these opportunistic diseases and early ART initiation in HIV-infected patients. Tenofovir-based regimens, unless contraindicated should be scaled up to replace AZT-based regimens as first line ART drugs.
BACKGROUND: Cohorts describing cause specific mortality in HIV-infectedpatients initiating antiretroviral therapy (ART) operate on an outpatient basis. Hospitalized patients represent the spectrum and burden of severe morbidity and mortality in patients on ART. OBJECTIVE: To determine the causes and outcomes of hospitalization among adults receiving ART. METHODS: A prospective cohort study. We enrolled 201 participants (50% female) with median (IQR) age and CD4 count of 34 (28-40) years and 91(29-211) cells/uL respectively. RESULTS: The most frequent causes of hospitalization were tuberculosis (TB) (37, 18%), cryptococcal meningitis (22, 11%), zidovudine (AZT) - associated anemia (19, 10%), sepsis (10, 5%) and Kaposi's sarcoma (10, 5%). Forty two patients (21%) died: 10 (24%) had TB, 8 (19%) had cryptococcal meningitis and 5 (12%) had sepsis, 9 (21%) had undiagnosed neurological syndromes while 10 (24%) had other illnesses. Predictors of death included low Karnofsky performance score of < 40 (OR, 21.1; CI 1.43- 31.6) and age >34 years (OR, 7.65; CI 1.09- 53.8). CONCLUSIONS: Opportunistic infections, malignancy and AZT-associated anemia contributed to most hospitalizations and mortality. It is important to intensify prevention, screening, and treatment for these opportunistic diseases and early ART initiation in HIV-infectedpatients. Tenofovir-based regimens, unless contraindicated should be scaled up to replace AZT-based regimens as first line ART drugs.
Authors: Rhoda Wanyenze; Moses Kamya; Cheryl A Liechty; Allan Ronald; David J Guzman; Fred Wabwire-Mangen; Harriet Mayanja-Kizza; David R Bangsberg Journal: AIDS Behav Date: 2006-07
Authors: David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware Journal: Clin Infect Dis Date: 2010-08-15 Impact factor: 9.079
Authors: Heidi van Rooyen; Nuala McGrath; Admire Chirowodza; Philip Joseph; Agnès Fiamma; Glenda Gray; Linda Richter; Thomas Coates Journal: AIDS Behav Date: 2013-11
Authors: Lisa A Spacek; Hasan M Shihab; Moses R Kamya; Doris Mwesigire; Allan Ronald; Harriet Mayanja; Richard D Moore; Michael Bates; Thomas C Quinn Journal: Clin Infect Dis Date: 2005-12-12 Impact factor: 9.079
Authors: Emilio Letang; James J Lewis; Mark Bower; Anisa Mosam; Margareth Borok; Thomas B Campbell; Denise Naniche; Tom Newsom-Davis; Fahmida Shaik; Suzanne Fiorillo; Jose M Miro; David Schellenberg; Philippa J Easterbrook Journal: AIDS Date: 2013-06-19 Impact factor: 4.177
Authors: Emily B Wong; Tanvier Omar; Gosetsemang J Setlhako; Regina Osih; Charles Feldman; David M Murdoch; Neil A Martinson; David R Bangsberg; W D F Venter Journal: PLoS One Date: 2012-10-16 Impact factor: 3.240
Authors: Asgeir Johannessen; Ezra Naman; Bernard J Ngowi; Leiv Sandvik; Mecky I Matee; Henry E Aglen; Svein G Gundersen; Johan N Bruun Journal: BMC Infect Dis Date: 2008-04-22 Impact factor: 3.090
Authors: Yao Abo; Marcel Zannou Djimon; Eugène Messou; Eric Balestre; Martial Kouakou; Jocelyn Akakpo; Carin Ahouada; Nathalie de Rekeneire; François Dabis; Charlotte Lewden; Albert Minga Journal: BMC Infect Dis Date: 2015-04-09 Impact factor: 3.090
Authors: Riley H Hazard; Peninah Kagina; Richard Kitayimbwa; Keneth Male; Melissa McShane; Dennis Mubiru; Emma Welikhe; Christopher C Moore; Amir Abdallah Journal: Open Forum Infect Dis Date: 2019-03-14 Impact factor: 3.835
Authors: Vanessa Quan; Sandra Toro-Silva; Charlotte Sriruttan; Verushka Chetty; Violet Chihota; Sophie Candfield; Anna Vassall; Alison D Grant; Nelesh P Govender Journal: PLoS One Date: 2019-12-12 Impact factor: 3.240
Authors: Mark W Tenforde; Alida M Gertz; David S Lawrence; Nicola K Wills; Brandon L Guthrie; Carey Farquhar; Joseph N Jarvis Journal: J Int AIDS Soc Date: 2020-01 Impact factor: 5.396